{"filing":{"accession_number":"0001628280-26-040784","cik":"0001237831","ticker":"GMED","company_name":"GLOBUS MEDICAL INC","form":"8-K","filing_date":"2026-06-04","report_date":null,"primary_document":"gmed-20260603.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1237831/000162828026040784/gmed-20260603.htm"},"events":[{"id":6962,"run_id":6104,"accession_number":"0001628280-26-040784","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"Globus Medical held its Annual Meeting of Stockholders and disclosed voting results on four proposals: election of two Class II directors (Keith W. Pfeil and Robert A. Douglas), approval of an amendment to the 2021 Equity Incentive Plan increasing authorized shares by 1,000,000, ratification of Deloitte \u0026 Touche LLP as independent auditor, and advisory approval of 2025 named executive officer compensation.","company_name":"GLOBUS MEDICAL INC","ticker":"GMED","filing_date":"2026-06-04","form":"8-K","submitted_at":null,"items":[{"id":4515,"accession_number":"0001628280-26-040784","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"The disclosure centers on stockholder approval of an amendment to the 2021 Equity Incentive Plan that increases authorized shares by 1,000,000 (from 11,000,000 to 12,000,000 shares). This is a material compensatory arrangement affecting the pool of equity available for director and officer compensation. The amendment directly impacts the Company's ability to grant equity awards to executives and is a classic Item 5.02(e) disclosure of a compensation plan amendment approved by shareholders.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-05T05:24:47.827017+00:00","company_name":"","ticker":null,"filing_date":""},{"id":4516,"accession_number":"0001628280-26-040784","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This Item 5.07 disclosure presents the complete voting results from Globus Medical's Annual Meeting of Stockholders on four proposals: election of two Class II directors (Keith W. Pfeil and Robert A. Douglas), approval of the 2021 Equity Incentive Plan Amendment, ratification of Deloitte \u0026 Touche LLP as independent auditor, and advisory approval of 2025 named executive officer compensation. The disclosure includes vote tallies (For, Against, Abstain, Broker Non-Vote) for each proposal, which is the standard format for shareholder vote results required under Item 5.07.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-05T05:24:47.827017+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":4515,"accession_number":"0001628280-26-040784","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"The disclosure centers on stockholder approval of an amendment to the 2021 Equity Incentive Plan that increases authorized shares by 1,000,000 (from 11,000,000 to 12,000,000 shares). This is a material compensatory arrangement affecting the pool of equity available for director and officer compensation. The amendment directly impacts the Company's ability to grant equity awards to executives and is a classic Item 5.02(e) disclosure of a compensation plan amendment approved by shareholders.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-05T05:24:47.827017+00:00","company_name":"GLOBUS MEDICAL INC","ticker":"GMED","filing_date":"2026-06-04"},{"id":4516,"accession_number":"0001628280-26-040784","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This Item 5.07 disclosure presents the complete voting results from Globus Medical's Annual Meeting of Stockholders on four proposals: election of two Class II directors (Keith W. Pfeil and Robert A. Douglas), approval of the 2021 Equity Incentive Plan Amendment, ratification of Deloitte \u0026 Touche LLP as independent auditor, and advisory approval of 2025 named executive officer compensation. The disclosure includes vote tallies (For, Against, Abstain, Broker Non-Vote) for each proposal, which is the standard format for shareholder vote results required under Item 5.07.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-05T05:24:47.827017+00:00","company_name":"GLOBUS MEDICAL INC","ticker":"GMED","filing_date":"2026-06-04"}]}